What 26 Analyst Ratings Have To Say About Veeva Systems

Comments
Loading...

Veeva Systems VEEV has been analyzed by 26 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 6 12 7 1 0
Last 30D 0 0 0 0 0
1M Ago 3 7 6 1 0
2M Ago 2 4 1 0 0
3M Ago 1 1 0 0 0

In the assessment of 12-month price targets, analysts unveil insights for Veeva Systems, presenting an average target of $264.27, a high estimate of $307.00, and a low estimate of $195.00. Observing a 7.81% increase, the current average has risen from the previous average price target of $245.13.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

A clear picture of Veeva Systems's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Craig Hettenbach Morgan Stanley Raises Underweight $195.00 $183.00
Anne Samuel JP Morgan Raises Neutral $218.00 $208.00
Tyler Radke Citigroup Raises Buy $307.00 $281.00
Steven Valiquette Mizuho Raises Outperform $280.00 $275.00
Allan Verkhovski Scotiabank Raises Sector Perform $240.00 $235.00
Saket Kalia Barclays Raises Overweight $275.00 $260.00
Kirk Materne Evercore ISI Group Raises In-Line $245.00 $220.00
Brad Sills B of A Securities Raises Neutral $290.00 $280.00
Rishi Jaluria RBC Capital Raises Outperform $285.00 $275.00
David Grossman Stifel Raises Buy $272.00 $240.00
Stan Berenshteyn Wells Fargo Raises Overweight $285.00 $275.00
Jailendra Singh Truist Securities Raises Hold $261.00 $207.00
David Hynes Canaccord Genuity Raises Hold $270.00 $210.00
Joe Vruwink Baird Raises Outperform $283.00 $275.00
Ryan MacDonald Needham Raises Buy $270.00 $260.00
Brent Bracelin Piper Sandler Raises Overweight $290.00 $280.00
Steven Valiquette Mizuho Announces Outperform $275.00 -
Allan Verkhovski Scotiabank Announces Sector Perform $235.00 -
David Grossman Stifel Raises Buy $240.00 $210.00
Saket Kalia Barclays Raises Overweight $260.00 $240.00
Rishi Jaluria RBC Capital Raises Outperform $275.00 $250.00
Ryan MacDonald Needham Maintains Buy $260.00 $260.00
Brent Bracelin Piper Sandler Raises Overweight $280.00 $230.00
Joe Vruwink Baird Lowers Outperform $245.00 $251.00
Andrew DeGasperi Exane BNP Paribas Announces Outperform $286.00 -
Jack Wallace Guggenheim Raises Buy $249.00 $233.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veeva Systems. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veeva Systems compared to the broader market.
  • Price Targets: Understanding forecasts, analysts offer estimates for Veeva Systems's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Veeva Systems's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Veeva Systems analyst ratings.

Discovering Veeva Systems: A Closer Look

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Veeva Systems: Financial Performance Dissected

Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.

Revenue Growth: Veeva Systems's remarkable performance in 3 months is evident. As of 31 October, 2024, the company achieved an impressive revenue growth rate of 13.41%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 26.57%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Veeva Systems's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.48%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Veeva Systems's ROA excels beyond industry benchmarks, reaching 2.91%. This signifies efficient management of assets and strong financial health.

Debt Management: With a below-average debt-to-equity ratio of 0.01, Veeva Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.

Understanding the Relevance of Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Good
62.5%
Technicals Analysis
100
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!